drugset
drugset / Trial / NCT05132049

Pharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and DA-5211-R2 in Healthy Adult Volunteers

NCT05132049 ↗

Phase 1 Completed 42 enrolled Dong-A ST Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

Pharmacokinetics and safety Profiles after administration of DA-5211 and co-administration of DA-5211-R1 and DA-5211-R2 in healthy adult volunteers

Timeline

Start
2021-12-18
Primary completion
2022-02-22
Completion
2022-02-22

Drugs

EvaluationDrugModalityDoseRoute
Subject DA-5211 Unknown — —
Subject DA-5211-R1 Unknown — —
Subject DA-5211-R2 Unknown — —

Indications

No indication recorded.